Clinical trialNCT05569057UnknownPhase 1Interventional

A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma

SponsorJiangsu Simcere Pharmaceutical Co., Ltd.Enrollment100Advanced Solid TumorCutaneous T-cell Lymphoma (CTCL)

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Henry Ford Health
Detroit, Michigan, United States
Ahmad Mattour, MD
Not, yet, recruiting
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Thomas Marron, MD
Not, yet, recruiting
Nyu Lagone Health
New York, New York, United States
Salman Punekar, MD
Not, yet, recruiting
Carolina Biooncology Institute
Huntersville, North Carolina, United States
John Powderly, MD
Recruiting
Mary Crowley Cancer Research
Dallas, Texas, United States
Douglas Orr, MD
Not, yet, recruiting
the University of Texas Md Anderson Cancer Center
Houston, Texas, United States
Sarina Piha-Paul, MD
Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Sept 2022
Primary completion: 1 Jun 2024
Completion: 31 Mar 2025
Last update posted: 7 Oct 2022
Registered enrollment: 100
Registry id: NCT05569057

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.